Study reveals mechanisms behind antidepressant effects of diabetes drug

FHS
March 6, 2024
6:23 pm

Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression.

50 years of lifesaving vaccinations: WHO’s EPI saves 154 million lives

The World Health Organization’s Expanded Programme on Immunization (EPI) has prevented 154 million deaths since 1974, significantly reducing global infant mortality and contributing 10.2 billion

May 7, 2024

Long-Term Data Support Non-Hormonal Drug for Hot-Flash Management

CHICAGO — The non-hormonal drug elinzanetant reduced the frequency of moderate-to-severe hot flashes in postmenopausal women, and seemed to have a favorable safety profile, according

September 16, 2024

Andexanet Shows Efficacy in Acute ICH With Factor Xa Inhibitors

Treatment with the bleeding reversal agent andexanet (Andexxa) in people with acute intracerebral hemorrhage on factor Xa inhibitors led to less expansion of hematoma volume

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.